Spotify Technology S.A. (SPOT)

Spotify's stock is trading near the top of its 52-week range after a run of gains, and the most recent move was the rise on the first session after the October 22, 2026 report, when it closed up 11.10% despite EPS of $2.48 falling 11.74% short of the $2.81 estimate. On November 13, 2026 the stock rose 2.36% to $612.63, sitting 4.96% below its 52-week high of $644.57. Six analyst firms kept their ratings on October 23, 2026, and CleaRank's score moved from 64/100 on November 12, 2026 to 68/100 on November 13, 2026, still a Buy. The question for the stock now is whether earnings growth can keep pace with a valuation that already sits well above its sector.

The October 22, 2026 report was a miss: adjusted EPS of $2.48 came in 11.74% below the $2.81 estimate. Even so, the stock rose 11.10% in the first session after the report. Earlier reports show the market has reacted to Spotify's results in both directions. The February 10, 2026 report beat by 59.35% and was followed by a 14.75% rise, while the April 28, 2026 beat of 17.35% was followed by a 12.43% fall. Across the six reports on the record, three beat and three missed, and the first-session move was lower after four of them. Results alone do not set the direction of the stock; the market is weighing guidance and growth more than a single quarter's EPS.

Of 41 analysts with a current rating, 32 rate the stock buy or strong buy, nine rate it hold, and none rate it sell. Three months ago, 34 of 41 ratings were buy. On October 23, 2026, Morgan Stanley, Oppenheimer, Piper Sandler, JP Morgan, Evercore ISI Group and Wells Fargo all kept their ratings, with Piper Sandler the only Neutral among them. The median 12-month target of $655.52 sits 7.0% above the price, and the highest target of $747.74 is the most optimistic view among the analysts. Analysts expect revenue to grow 13.5% this year, which is in line with the sector median growth of 13.9% that the company's own latest quarter also matched.

The stock trades at a trailing P/E of 37.33, a premium to peers, compared with a sector median of 23.3. Against those multiples, trailing GAAP EPS of $16.41 and a return on equity of 35.81% (against a sector median of 15.8%) show a highly profitable business, but the price already reflects a lot of that. Insiders sold $110.0M of stock over the last 18 months across 16 sales and made no open-market purchases. Such sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market buying would.

The base case is that the stock keeps its upward trend while analysts' earnings forecasts stay on track. Analysts expect EPS to grow 12.8% this fiscal year to $11.86 and 28.5% next year to $15.24, and revenue to grow 13.5% this year to $19.5B. If those forecasts hold, the current price of $612.63 sits 6.5% below the analysts' median 12-month target of $655.52, so the gap to that target is the main upside case. Analysts' targets run from $457.84 to $747.74. The main risk is the valuation: at a trailing P/E of 37.33 against a sector median of 23.3, the stock needs earnings to keep growing to justify the premium. A further earnings miss, like the one reported on October 22, 2026, would test that premium.

Support sits first at the 20-day exponential moving average of $584.24, the nearest level below the price. The next support is the 50-day simple moving average at $542.96, followed by the 200-day simple moving average at $502.26. The 52-week low of $405.00 is the furthest level below the price. Resistance is the 52-week high of $644.57, the only level above the price, and a move through it would mark a new high for the year.